Wide-Moat Stocks On Sale - The June 2020 Heat Map
by The FALCON MethodSummary
- Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating).
- We are only interested in those targets that are attractively valued in historical comparison.
- We share the heat map of the most investable candidates that may be worth your time for further analysis.
Step One: Wide-moat stocks with 5-star and 4-star ratings
Historical evidence says that while quality alone is a poor indicator of outperformance, when combined with a decent valuation filter, Morningstar’s moat rating proves to be more than useful. Based on the available data, stocks with a wide-moat rating that also fit into the 4- or 5-star category deserve to be the subject of further analysis. See the detailed explanation and the underlying evidence of our first step in this article.
We focus on those companies that are covered by a Morningstar analyst, as assigning a wide-moat rating without thorough analysis is a questionable practice in our opinion. We widened our scope to include the non-U.S. names as well this time. As of May 27, there were 176 wide-moat stocks meeting our criteria.
Only 6.8% (12 stocks) of this wide-moat group earned a 5-star (most attractive) valuation rating. Here are they:
Company Name | Ticker |
Ambev SA | ABEV |
Anheuser-Busch InBev SA/NV | BUD |
Baidu Inc. | BIDU |
Bayer AG | OTCPK:BAYRY |
British American Tobacco PLC | BTI |
Core Laboratories NV | CLB |
Imperial Brands PLC | OTCQX:IMBBY |
Julius Baer Gruppe AG | OTCPK:JBAXY |
Philip Morris International Inc. | PM |
The Toronto-Dominion Bank | TD |
Wells Fargo & Co. | WFC |
Westpac Banking Corp. | WBK |
We believe that the percentage of 5-star-rated wide-moat stocks is a good indicator of market sentiment. When this percentage is high, even the best companies are on sale. When the percentage is extremely low, market conditions may warrant caution. (Please note that this is not an indicator for market timing!)
As these best of breed companies may be worth a closer look even when they are just slightly cheaper than their fair value but are not in the bargain bin, we also list the 4-star-rated wide-moat stocks as of May 27:
Company Name | Ticker |
3M Co. | MMM |
Alibaba Group Holding Ltd. | BABA |
Altria Group Inc. | MO |
American Express Co. | AXP |
Applied Materials Inc. | AMAT |
Aspen Technology Inc. | AZPN |
BAE Systems PLC | OTCPK:BAESY |
Bank of America Corp. | BAC |
Berkshire Hathaway Inc. | BRK.B |
Biogen Inc. | BIIB |
Boeing Co. | BA |
Caterpillar Inc. | CAT |
Cerner Corp. | CERN |
Charles Schwab Corp. | SCHW |
Coca-Cola Co. | KO |
Comcast Corp. | CMCSA |
Compass Minerals International Inc. | CMP |
Constellation Brands Inc. | STZ |
Corteva Inc. | CTVA |
Deere & Co. | DE |
Enbridge Inc. | ENB |
Enterprise Products Partners LP | EPD |
General Dynamics Corp. | GD |
Gilead Sciences Inc. | GILD |
Harley-Davidson Inc. | HOG |
Honeywell International Inc. | HON |
Intel Corp. | INTC |
John Wiley & Sons Inc. | JW.A |
JPMorgan Chase & Co. | JPM |
Kellogg Co. | K |
Lockheed Martin Corp. | LMT |
Magellan Midstream Partners LP | MMP |
Medtronic PLC | MDT |
Merck & Co. Inc. | MRK |
Microchip Technology Inc. | MCHP |
PepsiCo Inc. | PEP |
Pfizer Inc. | PFE |
Raytheon Technologies Corp. | RTX |
Roche Holding AG | OTCQX:RHHBY |
Royal Bank of Canada | RY |
Salesforce.com Inc. | CRM |
Sanofi SA | SNY |
U.S. Bancorp | USB |
Unilever NV | UN |
Yum Brands Inc. | YUM |
Yum China Holdings Inc. | YUMC |
Zimmer Biomet Holdings Inc. | ZBH |
All in all, we have 59 firms that pass our very first criteria.
Step Two: Historical Valuation in the EVA Framework
We believe that the most widely used valuation multiples are terribly flawed. See this article on why we consider the Future Growth Reliance metric the best-of-breed sentiment indicator that addresses accounting distortions, thus gives us a true picture of which wide-moat companies seem attractively valued in historical terms. We want to buy our top-quality targets when the baked-in expectations are low, since that is when surprising on the upside has the highest probability. As investment is a game of probabilities, all we can do is stack the odds in our favor as much as possible.
35 of the 59 stocks survived this second step. Here’s the list:
Company Name | Ticker |
3M Co | MMM |
Alibaba Group Holding Ltd | BABA |
Altria Group Inc | MO |
Ambev SA | ABEV |
American Express Co | AXP |
Anheuser-Busch InBev SA/NV | BUD |
Aspen Technology Inc | AZPN |
Bank of America Corp | BAC |
Biogen Inc | BIIB |
British American Tobacco PLC | BTI |
Caterpillar Inc | CAT |
Cerner Corp | CERN |
Charles Schwab Corp | SCHW |
Coca-Cola Co | KO |
Comcast Corp | CMCSA |
Compass Minerals International Inc | CMP |
Core Laboratories NV | CLB |
Enterprise Products Partners LP | EPD |
General Dynamics Corp | GD |
Honeywell International Inc | HON |
Imperial Brands PLC | IMBBY |
John Wiley & Sons Inc | JW.A |
JPMorgan Chase & Co | JPM |
Kellogg Co | K |
Magellan Midstream Partners LP | MMP |
Merck & Co Inc | MRK |
PepsiCo Inc | PEP |
Philip Morris International Inc | PM |
Raytheon Technologies Corp | RTX |
Royal Bank of Canada | RY |
Salesforce.com Inc | CRM |
The Toronto-Dominion Bank | TD |
U.S. Bancorp | USB |
Wells Fargo & Co | WFC |
Westpac Banking Corp | WBK |
We are rather strict when it comes to historical valuation. There are stocks that unquestionably fail both or short- and long-term tests like Pfizer:
Source: evaexpress.com
There are some targets, however, that may look attractively valued if you only focus on the short-term (like the last 5 years), but the longer you zoom out, the more you lose your appetite. Lockheed Martin is a good example:
Source: evaexpress.com
It comes down to personal preference where you draw the line. For us, only those stocks are allowed to appear on the heat map in our third step that seem attractively valued in both a short-term and long-term context. (We go back as far as 20 years, calculate averages and medians on different time frames and let our algorithm do the ruthless work.)
Step Three: The Heat Map of the most investable wide-moat stocks
Seeing the stocks of our shortlist on a heat map with a quality and valuation axis is something that can prove very useful when we need to make a decision on which candidates to analyze thoroughly. As explained in our previous article, we use the PRVit (Performance-Risk-Valuation investment technology) model of the EVA Dimensions team.
All in all, PRVit is a multifactor quantitative stock selection model based on EVA-centric measures of Performance, Risk, and Valuation. It first estimates the fundamental value of a company based on its risk-adjusted EVA performance (shown on the vertical axis) and then compares it to its actual valuation (shown on the horizontal axis). All factors in this model were chosen heuristically based on common sense, and not by data mining, yet strong and statistically significant backtests prove the soundness of the PRVit approach both in the U.S. and globally. (See the details here.)
Here is the heat map as of May 27:
Source: evaexpress.com
We also present the results in a table format to make your decision easier.
Source: evaexpress.com, Morningstar
(Stocks highlighted in light blue are Morningstar’s 5-star-rated wide-moat names that survived the second step of our process.)
Each company has a composite 0-100 score in each category, where higher is better for Performance and lower is better for Risk and Valuation. We believe that stocks in the upper quintile of the PRVit ranking (with a PRVit score above 80) are worth a closer look.
I plan to run this three-step process on a monthly basis and publish the shortlist of targets it produces. Also, I am hopeful that the members of my FALCON Team will publish thorough analyses of the most promising targets. If you don't want to miss any of these pieces in the future, please scroll up and click "Follow" next to my name.
Disclosure: I am/we are long PM, WFC, MMM, MO, BRK.B, KO, ENB, GILD, PEP. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.